| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.42▼ | 3.45▼ | 3.45▼ | 3.38▲ | 3.45▼ |
| MA10 | 3.43▼ | 3.46▼ | 3.46▼ | 3.40▼ | 3.25▲ |
| MA20 | 3.46▼ | 3.46▼ | 3.43▼ | 3.46▼ | 2.85▲ |
| MA50 | 3.47▼ | 3.40▼ | 3.40▼ | 3.16▲ | 2.47▲ |
| MA100 | 3.45▼ | 3.40▼ | 3.42▼ | 2.79▲ | 2.43▲ |
| MA200 | 3.42▼ | 3.43▼ | 3.33▲ | 2.49▲ | 3.43▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.010▼ | -0.003▼ | -0.030▼ | 0.057▲ |
| RSI | 27.467▼ | 40.350▼ | 45.020▼ | 53.067▲ | 65.357▲ |
| STOCH | 5.736▼ | 51.759 | 62.134 | 42.300 | 78.187 |
| WILL %R | -94.444▼ | -95.000▼ | -95.000▼ | -53.947 | -20.701▲ |
| CCI | -151.351▼ | -166.447▼ | -181.921▼ | 12.651 | 76.821 |
|
Wednesday, February 04, 2026 08:00 AM
**NM signifies a non meaningful value. A dash signifies the data is not available.
|
|
Tuesday, January 13, 2026 05:00 AM
Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is ...
|
|
Tuesday, January 13, 2026 12:00 AM
Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/02/26 | 3.40 | 3.49 | 3.385 | 3.395 | 152,358 |
| 09/02/26 | 3.40 | 3.49 | 3.3593 | 3.43 | 164,317 |
| 06/02/26 | 3.28 | 3.41 | 3.22 | 3.41 | 167,214 |
| 05/02/26 | 3.37 | 3.50 | 3.24 | 3.24 | 210,634 |
| 04/02/26 | 3.45 | 3.5227 | 3.39 | 3.42 | 205,888 |
| 03/02/26 | 3.41 | 3.44 | 3.33 | 3.41 | 115,191 |
| 02/02/26 | 3.33 | 3.45 | 3.27 | 3.40 | 150,572 |
| 30/01/26 | 3.40 | 3.415 | 3.29 | 3.37 | 140,492 |
| 29/01/26 | 3.47 | 3.51 | 3.37 | 3.42 | 134,015 |
| 28/01/26 | 3.46 | 3.59 | 3.42 | 3.47 | 177,586 |
|
|
||||
|
|
||||
|
|